elliptinium has been researched along with Carcinoma, Small Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahomadegbe, JC; LeFevre, D; Multon, E; Riou, G; Riou, JF | 1 |
| Beaujean, F; Benard, J; Bettan-Renaud, L; Gavoille, A; Lopez, M; Pico, JL; Riou, G | 1 |
2 other study(ies) available for elliptinium and Carcinoma, Small Cell
| Article | Year |
|---|---|
Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417.
Topics: Alkaloids; Amsacrine; Antineoplastic Agents; Carcinoma, Small Cell; Cell Division; Cell Line; DNA; DNA Damage; DNA Topoisomerases, Type II; Ellipticines; Humans; Lung Neoplasms; Tumor Cells, Cultured | 1989 |
In vitro chemical eradication of small cell lung cancer: application in autologous bone marrow transplantation.
Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Transplantation; Carbazoles; Carcinoma, Small Cell; Cell Line; Cell Survival; Cisplatin; Cyclophosphamide; Doxorubicin; Ellipticines; Etoposide; Humans; Intercalating Agents; Lung Neoplasms; Transplantation, Autologous; Tumor Cells, Cultured | 1988 |